Position in ARGX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$121,951
+$38,697 QoQ
Shares Held
167
+68.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Accent Capital Management, LLC holds $294,025 across 17 Biotechnology names. ARGX ranks #1 (41.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
167 | $121,951 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
70 | $36,642 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
347 | $32,055 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
310 | $25,819 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
50 | $16,109 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
188 | $9,911 | |
| 7 | NRIX |
Nurix Therapeutics, Inc.
|
568 | $8,804 | |
| 8 | KOD |
Kodiak Sciences Inc.
|
230 | $8,767 |
All Filings in ARGX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $121,951 | 167 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $83,254 | 99 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $73,018 | 99 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $54,570 | 99 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $46,165 | 78 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $47,970 | 78 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $42,282 | 78 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $29,242 | 68 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $20,867 | 53 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $20,162 | 53 | Shares | Sole | 2024-03-19 | |
| No filing history on record for this holder in this stock. | ||||||